V-GO DISPOSABLE INSULIN DELIVERY DEVICE V-GO 30

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 04,consumer report with the FDA on 2014-04-09 for V-GO DISPOSABLE INSULIN DELIVERY DEVICE V-GO 30 manufactured by Valeritas, Llc.

Event Text Entries

[4554988] Diabetic patient type 1 per pt. On v-go 30 using novolog reported to valeritas customer care (vcc) high blood glucose readings and was reportedly hospitalized in icu for 4 days. The pt. Indicated he was initially switched from the vgo 20 to the vgo 30 because he was experiencing hyperglycemia. The pt's aic test was around 7 percent pre-v-go and rose to 9 percent he reported in j(b)(6) while using the v-go. The pt reported he was hospitalized with a diagnosis of diabetic ketoacidosis (dka) on (b)(6) 2014 and released on (b)(6) 2014. Blood glucose had risen to 500-600s. He was readmitted (b)(6) 2014 and again released on (b)(6) 2014. Blood glucose had risen to the 400's. The patient reported to valeritas adverse event assessor that the gray indicator on the v-gos hwe used had moved as far as possible indicating the insulin was delivered by the vgo. The pt. Had experienced vomiting and feeling poorly. His white blood count was 19,000 but the hospital tests could not find any infection his wife indicated. The pt's health care provider indicated to the pt. The only explanation they had for the hyperglycemia and dka was the vgo was not delivering insulin.
Patient Sequence No: 1, Text Type: D, B5


[11795870] Procedure requires filing and mdr based on the following information: cases involving ketoacidosis unless there is a clear explanation not involving the device. Three devices were returned for investigation. All three devices show no evidence of malfunction. There is evidence that the devices had insulin in them although it could not be determined whether the devices had been completely filled with insulin. Therefore, there was no clear explanation for the dka. See scanned pages.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1226572-2014-00005
MDR Report Key3750755
Report Source04,CONSUMER
Date Received2014-04-09
Date of Report2014-03-10
Date of Event2014-03-06
Date Mfgr Received2014-03-10
Date Added to Maude2014-04-16
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactSCOTT HUIE
Manufacturer Street750 ROUTE 202S SUITE 600
Manufacturer CityBRIDGEWATER NJ 08807
Manufacturer CountryUS
Manufacturer Postal08807
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameV-GO DISPOSABLE INSULIN DELIVERY DEVICE
Generic NameV-GO
Product CodeKZE
Date Received2014-04-09
Returned To Mfg2014-03-27
Model NumberV-GO 30
Lot NumberVG312060
Device Expiration Date2014-07-01
OperatorLAY USER/PATIENT
Device AvailabilityY
Device AgeDA
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerVALERITAS, LLC
Manufacturer Address750 ROUTE 202 SOUTH STE 600 BRIDGEWATER NJ 008072597 US 008072597


Patients

Patient NumberTreatmentOutcomeDate
101. Hospitalization 2014-04-09

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.